In 2005, Kaplan found that myeloid hematopoietic progenitors expressing vascular endothelial growth factor receptor 1 (VEGFR1) arrived at the host organ before tumor cells and changed the microenvironment there (2). The gene discussed is FLT1; the disease is neoplasm.